Navigation Links
Ann Arbor firm with UW drug tech goes public

QuatRx Pharmaceuticals Co., a pharmaceutical firm in Ann Arbor, Michigan, that licensed some of University of Wisconsin-Madison professor Hector DeLuca's technology in 2002, has filed for an IPO.

One of the company's five products is a treatment for psoriasis, a skin disease, based on DeLuca's work at UW-Madison and Deltanoid Pharmaceuticals. It is licensed through the Wisconsin Alumni As......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 02/15/06


Page: 1

Related biology technology :

1. 2006: A great biotech financing year, unless you were going public!
2. TomoTherapys 100th radiology system reaches public sector
3. With patents and research tools, when is private really public?
4. Brady Corp. raises $137 million in public offering
5. In public attitudes about taxes and spending, Wisconsin is Jekyll and Hyde
6. Republican sees nothing wrong with Doyles use of executive order
7. Anthropology professors blog raises public interest
8. Building the modern public-purpose university should be UW Systems goal
9. Republicans propose sweeping changes to promote investment
10. UW offers new program in neuroscience and public policy
11. Funds will support public safety communications interoperabilty
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):